UTHR

#486
United Therapeutics Corporation - Common Stock
556.8 2 USD
-0.94%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
556.82
556.82
Intervallo Annuale
272.17
609.35
Variazione giornaliera
-0.94%
Variazione Mensile
-3.07%
Variazione di 6 mesi
+14.88%
Variazione Annuale
+73.91%
Chiusura Precedente
562.0 9
Open
556.8 2
Minimo
556.8 2
High
556.8 2
Volume
198
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 23.64 B
  • Employee 1 400
  • Founded 1996
  • CEO N/A
  • Website www.unither.com
  • Headquarter Delaware, United States
  • FIGI BBG000BV4XJ1
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
21.92
Rapporto prezzo/fatturato
8.92

United Therapeutics Corporation - Common Stock

United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.

Notizie